These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 31144462)

  • 1. The genital tract and rectal microbiomes: their role in HIV susceptibility and prevention in women.
    Abdool Karim SS; Baxter C; Passmore JS; McKinnon LR; Williams BL
    J Int AIDS Soc; 2019 May; 22(5):e25300. PubMed ID: 31144462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Characteristics and physiologic role of female lower genital microbiome].
    Marschalkó M; Ambrus L
    Orv Hetil; 2023 Jun; 164(24):923-930. PubMed ID: 37330978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The microbiome and HIV prevention strategies in women.
    Abdool Karim SS; Passmore JS; Baxter C
    Curr Opin HIV AIDS; 2018 Jan; 13(1):81-87. PubMed ID: 29059077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diversity of vaginal microbiota in sub-Saharan Africa and its effects on HIV transmission and prevention.
    Bayigga L; Kateete DP; Anderson DJ; Sekikubo M; Nakanjako D
    Am J Obstet Gynecol; 2019 Feb; 220(2):155-166. PubMed ID: 30321529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbial Composition Predicts Genital Tract Inflammation and Persistent Bacterial Vaginosis in South African Adolescent Females.
    Lennard K; Dabee S; Barnabas SL; Havyarimana E; Blakney A; Jaumdally SZ; Botha G; Mkhize NN; Bekker LG; Lewis DA; Gray G; Mulder N; Passmore JS; Jaspan HB
    Infect Immun; 2018 Jan; 86(1):. PubMed ID: 29038128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metagenomic Shotgun Sequencing of Endocervical, Vaginal, and Rectal Samples among Fijian Women with and without Chlamydia trachomatis Reveals Disparate Microbial Populations and Function across Anatomic Sites: a Pilot Study.
    Bommana S; Richards G; Kama M; Kodimerla R; Jijakli K; Read TD; Dean D
    Microbiol Spectr; 2022 Jun; 10(3):e0010522. PubMed ID: 35579443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Vaginal Microbiome and its Potential to Impact Efficacy of HIV Pre-exposure Prophylaxis for Women.
    Velloza J; Heffron R
    Curr HIV/AIDS Rep; 2017 Oct; 14(5):153-160. PubMed ID: 28812207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The significance of Lactobacillus crispatus and L. vaginalis for vaginal health and the negative effect of recent sex: a cross-sectional descriptive study across groups of African women.
    Jespers V; van de Wijgert J; Cools P; Verhelst R; Verstraelen H; Delany-Moretlwe S; Mwaura M; Ndayisaba GF; Mandaliya K; Menten J; Hardy L; Crucitti T;
    BMC Infect Dis; 2015 Mar; 15():115. PubMed ID: 25879811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shifts in microbial diversity, composition, and functionality in the gut and genital microbiome during a natural SIV infection in vervet monkeys.
    Jasinska AJ; Dong TS; Lagishetty V; Katzka W; Jacobs JP; Schmitt CA; Cramer JD; Ma D; Coetzer WG; Grobler JP; Turner TR; Freimer N; Pandrea I; Apetrei C
    Microbiome; 2020 Nov; 8(1):154. PubMed ID: 33158452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing the vaginal microbiome as a potential strategy to reduce heterosexual HIV transmission.
    Armstrong E; Kaul R; Cohen CR
    J Intern Med; 2023 Apr; 293(4):433-444. PubMed ID: 36544257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lactobacillus-Deficient Cervicovaginal Bacterial Communities Are Associated with Increased HIV Acquisition in Young South African Women.
    Gosmann C; Anahtar MN; Handley SA; Farcasanu M; Abu-Ali G; Bowman BA; Padavattan N; Desai C; Droit L; Moodley A; Dong M; Chen Y; Ismail N; Ndung'u T; Ghebremichael MS; Wesemann DR; Mitchell C; Dong KL; Huttenhower C; Walker BD; Virgin HW; Kwon DS
    Immunity; 2017 Jan; 46(1):29-37. PubMed ID: 28087240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Influence of Cervicovaginal Microbiota on Mucosal Immunity and Prophylaxis in the Battle against HIV.
    Farcasanu M; Kwon DS
    Curr HIV/AIDS Rep; 2018 Feb; 15(1):30-38. PubMed ID: 29516267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of reproductive aging on the vaginal microbiome and soluble immune mediators in women living with and at-risk for HIV infection.
    Murphy K; Keller MJ; Anastos K; Sinclair S; Devlin JC; Shi Q; Hoover DR; Starkman B; McGillick J; Mullis C; Minkoff H; Dominguez-Bello MG; Herold BC
    PLoS One; 2019; 14(4):e0216049. PubMed ID: 31026271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Vaginal Microbiome in U.S. Black Women: A Systematic Review.
    Wells JS; Chandler R; Dunn A; Brewster G
    J Womens Health (Larchmt); 2020 Mar; 29(3):362-375. PubMed ID: 32109181
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of oral pre-exposure prophylaxis (PrEP) for HIV among women with abnormal vaginal microbiota: a post-hoc analysis of the randomised, placebo-controlled Partners PrEP Study.
    Heffron R; McClelland RS; Balkus JE; Celum C; Cohen CR; Mugo N; Bukusi E; Donnell D; Lingappa J; Kiarie J; Fiedler T; Munch M; Fredricks DN; Baeten JM;
    Lancet HIV; 2017 Oct; 4(10):e449-e456. PubMed ID: 28732773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-Sectional Analysis of Selected Genital Tract Immunological Markers and Molecular Vaginal Microbiota in Sub-Saharan African Women, with Relevance to HIV Risk and Prevention.
    Kyongo JK; Crucitti T; Menten J; Hardy L; Cools P; Michiels J; Delany-Moretlwe S; Mwaura M; Ndayisaba G; Joseph S; Fichorova R; van de Wijgert J; Vanham G; Ariën KK; Jespers V
    Clin Vaccine Immunol; 2015 May; 22(5):526-38. PubMed ID: 25761460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rectal Microbiome Composition Correlates with Humoral Immunity to HIV-1 in Vaccinated Rhesus Macaques.
    Elizaldi SR; Verma A; Walter KA; Rolston M; Dinasarapu AR; Durbin-Johnson BP; Settles M; Kozlowski PA; Raeman R; Iyer SS
    mSphere; 2019 Dec; 4(6):. PubMed ID: 31826975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbial mismanagement: how inadequate treatments for vaginal dysbiosis drive the HIV epidemic in women.
    Gustin A; Cromarty R; Schifanella L; Klatt NR
    Semin Immunol; 2021 Jan; 51():101482. PubMed ID: 34120819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Standard Bacterial Vaginosis Treatment on the Genital Microbiota, Immune Milieu, and Ex Vivo Human Immunodeficiency Virus Susceptibility.
    Joag V; Obila O; Gajer P; Scott MC; Dizzell S; Humphrys M; Shahabi K; Huibner S; Shannon B; Tharao W; Mureithi M; Oyugi J; Kimani J; Kaushic C; Ravel J; Anzala O; Kaul R
    Clin Infect Dis; 2019 May; 68(10):1675-1683. PubMed ID: 30407498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaginal microbiota and susceptibility to HIV.
    Eastment MC; McClelland RS
    AIDS; 2018 Mar; 32(6):687-698. PubMed ID: 29424773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.